The association between critical illness and changes in bone turnover in adults: a systematic review

Osteoporosis International

Volumn 25, Issue 10, 2014, Pages 2335-2346

  Orford, N ^a,b   Cattigan, C ^b   Brennan, S L ^b,c   Kotowicz, M ^b,c   Pasco, J ^b   Cooper, D J ^a  

^a MONASH UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone turnover; Critical care; Intensive care; Mechanical ventilation; Osteoporosis

Indexed keywords

BONE DENSITY; BONE TURNOVER; CASE CONTROL STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; FRACTURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; OSSIFICATION; REVIEW; SYSTEMATIC REVIEW; BONE REMODELING; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

BONE DENSITY; BONE REMODELING; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE; OSTEOPOROSIS;

EID: 84919415766     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2734-1     Document Type: Review

References (43)

1. Cuthbertson BH, Scott JE, Strachan M, Kilonzo M, Vale L (2005) Quality of life before and after intensive care. Anaesthesia 60:332–339
2. Niskanen M, Ruokonen E, Takala J, Rissanen P, Kari A (1999) Quality of life after prolonged intensive care. Crit Care Med 27:1132–1139
3. Herridge MS, Cheung AM, Tansey CM et al (2003) One-year outcome in survivors of the acute respiratory distress syndrome. N Engl J Med 348(8):683–693
4. Chelluri L, Pinsky MR, Donahoe MP, Grenvik A (1993) Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 269(24):3119–3123
5. Dowdy DW, Eid MP, Sedrakyan A et al (2005) Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Med 31(7):1007
6. Angus DC, Carlet J (2003) Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med 29(3):368–377
7. Douglas SL, Daly BJ, Kelley CG, O’Toole E, Montenegro H (2005) Impact of a disease management program upon caregivers of chronically critically ill patients. Chest 128(6):3925–3936
8. Nguyen TV, Center JR, Eisman JA (2004) Osteoporosis: underrated, underdiagnosed and undertreated. MJA 180:S18–S22
9. Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841–1850
10. Andrade SE, Majumdar SR, Chan A et al (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052–2057
11. Vestergaard P, Rejnmark L, Mosekilde L (2005) Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int 16(2):134–141
12. Griffith DM, Walsh TS (2011) Bone loss during critical illness: a skeleton in the closet for the intensive care unit survivor? Crit Care Med 39(6):1554–1556
13. Via MA, Gallagher EJ, Mechanick JI (2010) Bone physiology and therapeutics in chronic critical illness. Ann N Y Acad Sci 1211:85–94
14. Hollander JM, Mechanick JI (2009) Bisphosphonates and metabolic bone disease in the ICU. Curr Opin Clin Nutr Metab Care 12(2):190–195
15. Lievense AM, Bierma-Zeinstra SMA, Verhagen AP, Van Baar ME, Verhaar JAN, Koes BW (2002) Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology 41:1155–1162
16. Brennan SL, Pasco JA, Urquhart DM, Oldenburg B, Wang Y, Wluka AE (2010) Association between socioeconomic status and bone mineral density in adults: a systematic review. Osteoporos Int 22(2):517–527
17. Chalmers TC, Smith H, Blackburn B et al (1981) A method for assessing the quality of a randomized control trial. Control Clin Trials 2:31–39
18. Orford NR, Saunders K, Merriman E et al (2011) Skeletal morbidity among survivors of critical illness. Crit Care Med 39(6):1295–1300
19. Nierman DM, Mechanick JI (1998) Bone hyperresorption is prevalent in chronically critically ill patients. Chest 114(4):1122–1128
20. Lind L, Carlstedt F, Rastad J et al (2000) Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 28(1):93–99
21. Nierman DM, Mechanick JI (2000) Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest 118(3):761–766
22. Van den Berghe G, Baxter RC, Weekers F et al (2002) The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxford) 56(5):655–669
23. Van den Berghe G, Weekers F, Baxter RC et al (2001) Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab 86(7):3217–3226
24. Van den Berghe G, Wouters P, Weekers F et al (1999) Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 84:1311–1323
25. Owen HC, Vanhees I, Solie L et al (2012) Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalities. J Bone Miner Res 27(7):1541–1552
26. Van den Berghe G, Roosbroeck DV, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R (2003) Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88(10):4623–4632
27. Smith LM, Cuthbertson B, Harvie J, Webster N, Robins S, Ralston SH (2002) Increased bone resorption in the critically ill: association with sepsis and increased nitric oxide production. Crit Care Med 30(4):837–840
28. Shapses SA, Weissman C, Seibel MJ, Chowdhury HA (1997) Urinary pyridinium cross-link excretion is increased in critically ill surgical patients. Crit Care Med 25(1):85–90
29. Vasikaran S, Eastell R, Bruyère O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391–420
30. Mechanick JI, Brett EM (2002) Endocrine and metabolic issues in the management of the chronically critically ill patient. Crit Care Clin 18(3):619–641
31. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936
32. Tamaki J, Iki M, Kadowaki E et al (2013) Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 24(3):887–897
33. Nishizawa Y, Ohta H, Miura M et al (2012) Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab 31(1):1–15
34. Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover—uses and limitations. Ann Clin Biochem 51:189–202
35. Kotowicz MA, Hall S, Hunder GG et al (1990) Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum 33(10):1487–1492
36. Seibel MJ, Eastell R, Garnero P, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11(suppl 6):S2–S17
37. Vasikaran S, Cooper C, Eastell R et al (2011) International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 49(8):1271–1274
38. Pasco JA, Kotowicz MA, Henry MJ et al (2006) High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 296(11):1353–1354
39. Frenkel B, Hong A, Baniwal SK et al (2010) Regulation of adult bone turnover by sex steroids. J Cell Physiol 224:305–310
40. Sambrook PN, Chen CJ, March L et al (2006) High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 21(4):549–555
41. Lerchbaum E, Schwetz V, Pilz S et al (2013) Association of bone turnover markers with mortality in men referred to coronary angiography. Osteoporos Int 24(4):1321–1332
42. Via MA, Potenza MV, Hollander J et al (2012) Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness. J Intensive Care Med 27(5):312–318
43. Delmas PD, Adami S, Strugala C et al (2006) Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum 54(6):1838–1846